TIM50 peptide

  • Check with publisher
  • Published date: July 23, 2019
    • Shirley, New York, United States

TIMM50 (translocase of inner mitochondrial membrane 50 homolog (S. cerevisiae)) is a protein-coding gene. Diseases associated with TIMM50 include spinal muscular atrophy, and muscular atrophy, and among its related super-pathways are Post-translational protein modification. GO annotations related to this gene include RNA binding and protein serine/threonine phosphatase activity.
https://www.creative-diagnostics.com/TIM50-peptide-180132-436.htm

Result 0 votes
Thomas Schmitt
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • 5th Annual ComplianceOnline Medical Device Summit 2020

    5th Annual ComplianceOnline Medical Device Summit 2020

    Life Sciences Massachusetts (Boston) February 12, 2020 Check with publisher

    ComplianceOnline Medical Device Summit 2020 brings together Speakers and executives from FDA/CDRH, Ex-FDA Officials and Renowned R&D experts and technology innovators to share information regarding opportunities, obstacles, best practices and cha...

  • 4th Annual Genome Editing USA Congress

    4th Annual Genome Editing USA Congress

    Life Sciences Boston (Massachusetts) December 23, 2019 Check with publisher

    350+ end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical & biotech companies. 3 outstanding programmes bringing together ...

  • 6th Annual Single Cell Analysis USA Congress

    6th Annual Single Cell Analysis USA Congress

    Life Sciences Boston (Massachusetts) December 16, 2019 Check with publisher

    350+ end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical & biotech companies. 3 outstanding programmes bringing together ...